Compare · HLN vs WALD
HLN vs WALD
Side-by-side comparison of Haleon plc (HLN) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HLN and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- HLN is the larger of the two at $45.33B, about 259.2x WALD ($174.9M).
- HLN has been more active in the news (14 items in the past 4 weeks vs 4 for WALD).
- HLN has more recent analyst coverage (19 ratings vs 11 for WALD).
- Company
- Haleon plc
- Waldencast plc
- Price
- -
- -
- Market cap
- $45.33B
- $174.9M
- 1M return
- +2.46%
- -
- 1Y return
- +5.76%
- -
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2021
- News (4w)
- 14
- 4
- Recent ratings
- 19
- 11
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest HLN
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes
- SEC Form 6-K filed by Haleon plc
- Centrum Reframes Healthy Aging as a Proactive Practice for Adults 35 and Beyond
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes
Latest WALD
- SEC Form 4 filed by Chief Executive Officer Brousset Michel
- SEC Form 4 filed by Chief Growth Officer Sebti Hind
- Chief Financial Officer Manfredi Manuel converted options into 79,289 units of Class A Ordinary Shares, increasing direct ownership by 200% to 118,933 units (SEC Form 4)
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel